Industry: Medical Devices & Consumables
Published Date: 2026-01-19
Pages: 112 Pages
Report ld: 5746559
Request Sample
Customized Report
Muscle-on-a-Chip Market Size(US$)

CAGR 2026-2032
26.1%
Market Size,2032
USD 1,784
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Muscle-on-a-Chip was estimated to be worth US$ 359 million in 2025 and is projected to reach US$ 1784 million, growing at a CAGR of 26.1% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Muscle-on-a-Chip cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
As an emerging market segment in the biomedical field, the muscle chip market has gradually attracted widespread attention from the industry in recent years. Muscle chips can simulate the structure and function of muscle tissue, providing a powerful tool for the research of muscle-related diseases, drug development and personalized medicine. Muscle chips have broad application potential in multiple fields, including diagnosis of muscle diseases, drug screening, toxicity testing, sports rehabilitation, and personalized medicine. By simulating the physiological and pathological processes of muscle tissue, muscle chips can help researchers gain a deeper understanding of the pathogenesis of muscle diseases, accelerate drug development, and improve treatment effects. Overall, the muscle chip market has broad development prospects and huge market potential.
This report provides a comprehensive view of the global market for Muscle-on-a-Chip, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Muscle-on-a-Chip market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Muscle-on-a-Chip.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Muscle-on-a-Chip manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Muscle-on-a-Chip sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Muscle-on-a-Chip sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Muscle-on-a-Chip Product Introduction
1.2 Global Muscle-on-a-Chip Market Size Forecast
1.2.1 Global Muscle-on-a-Chip Sales Value (2021–2032)
1.2.2 Global Muscle-on-a-Chip Sales Volume (2021–2032)
1.2.3 Global Muscle-on-a-Chip Sales Price (2021–2032)
1.3 Muscle-on-a-Chip Market Trends & Drivers
1.3.1 Muscle-on-a-Chip Industry Trends
1.3.2 Muscle-on-a-Chip Market Drivers & Opportunities
1.3.3 Muscle-on-a-Chip Market Challenges
1.3.4 Muscle-on-a-Chip Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Muscle-on-a-Chip Players Revenue Ranking (2025)
2.2 Global Muscle-on-a-Chip Revenue by Company (2021–2026)
2.3 Global Muscle-on-a-Chip Sales Volume Ranking of Players (2025)
2.4 Global Muscle-on-a-Chip Sales Volume by Company (2021–2026)
2.5 Global Muscle-on-a-Chip Average Price by Company (2021–2026)
2.6 Key Manufacturers Muscle-on-a-Chip Manufacturing Base and Headquarters
2.7 Key Manufacturers Muscle-on-a-Chip Product Offerings
2.8 Key Manufacturers Start of Mass Production of Muscle-on-a-Chip
2.9 Muscle-on-a-Chip Market Competitive Analysis
2.9.1 Muscle-on-a-Chip Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Muscle-on-a-Chip Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Muscle-on-a-Chip revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Muscle-on-a-Chip Market Classification
3.1 Introduction by Type
3.1.1 Skeletal Muscle
3.1.2 Smooth Muscle
3.1.3 Other
3.1.4 Global Muscle-on-a-Chip Sales Value by Type
3.1.4.1 Global Muscle-on-a-Chip Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Muscle-on-a-Chip Sales Value, by Type (2021–2032)
3.1.4.3 Global Muscle-on-a-Chip Sales Value, by Type (%), 2021–2032
3.1.5 Global Muscle-on-a-Chip Sales Volume by Type
3.1.5.1 Global Muscle-on-a-Chip Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Muscle-on-a-Chip Sales Volume, by Type (2021–2032)
3.1.5.3 Global Muscle-on-a-Chip Sales Volume, by Type (%), 2021–2032
3.1.6 Global Muscle-on-a-Chip Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical R&D
4.1.2 Sports Medicine
4.1.3 Sports Equipment Development
4.2 Global Muscle-on-a-Chip Sales Value by Application
4.2.1 Global Muscle-on-a-Chip Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Muscle-on-a-Chip Sales Value, by Application (2021–2032)
4.2.3 Global Muscle-on-a-Chip Sales Value, by Application (%), 2021–2032
4.3 Global Muscle-on-a-Chip Sales Volume by Application
4.3.1 Global Muscle-on-a-Chip Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Muscle-on-a-Chip Sales Volume, by Application (2021–2032)
4.3.3 Global Muscle-on-a-Chip Sales Volume, by Application (%), 2021–2032
4.4 Global Muscle-on-a-Chip Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Muscle-on-a-Chip Sales Value by Region
5.1.1 Global Muscle-on-a-Chip Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Muscle-on-a-Chip Sales Value by Region (2021–2026)
5.1.3 Global Muscle-on-a-Chip Sales Value by Region (2027–2032)
5.1.4 Global Muscle-on-a-Chip Sales Value by Region (%), 2021–2032
5.2 Global Muscle-on-a-Chip Sales Volume by Region
5.2.1 Global Muscle-on-a-Chip Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Muscle-on-a-Chip Sales Volume by Region (2021–2026)
5.2.3 Global Muscle-on-a-Chip Sales Volume by Region (2027–2032)
5.2.4 Global Muscle-on-a-Chip Sales Volume by Region (%), 2021–2032
5.3 Global Muscle-on-a-Chip Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Muscle-on-a-Chip Sales Value, 2021–2032
5.4.2 North America Muscle-on-a-Chip Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Muscle-on-a-Chip Sales Value, 2021–2032
5.5.2 Europe Muscle-on-a-Chip Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Muscle-on-a-Chip Sales Value, 2021–2032
5.6.2 Asia Pacific Muscle-on-a-Chip Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Muscle-on-a-Chip Sales Value, 2021–2032
5.7.2 South America Muscle-on-a-Chip Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Muscle-on-a-Chip Sales Value, 2021–2032
5.8.2 Middle East & Africa Muscle-on-a-Chip Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Muscle-on-a-Chip Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Muscle-on-a-Chip Sales Value and Sales Volume
6.2.1 Key Countries/Regions Muscle-on-a-Chip Sales Value, 2021–2032
6.2.2 Key Countries/Regions Muscle-on-a-Chip Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Muscle-on-a-Chip Sales Value, 2021–2032
6.3.2 United States Muscle-on-a-Chip Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Muscle-on-a-Chip Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Muscle-on-a-Chip Sales Value, 2021–2032
6.4.2 Europe Muscle-on-a-Chip Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Muscle-on-a-Chip Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Muscle-on-a-Chip Sales Value, 2021–2032
6.5.2 China Muscle-on-a-Chip Sales Value by Type (%), 2025 vs 2032
6.5.3 China Muscle-on-a-Chip Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Muscle-on-a-Chip Sales Value, 2021–2032
6.6.2 Japan Muscle-on-a-Chip Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Muscle-on-a-Chip Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Muscle-on-a-Chip Sales Value, 2021–2032
6.7.2 South Korea Muscle-on-a-Chip Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Muscle-on-a-Chip Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Muscle-on-a-Chip Sales Value, 2021–2032
6.8.2 Southeast Asia Muscle-on-a-Chip Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Muscle-on-a-Chip Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Muscle-on-a-Chip Sales Value, 2021–2032
6.9.2 India Muscle-on-a-Chip Sales Value by Type (%), 2025 vs 2032
6.9.3 India Muscle-on-a-Chip Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Emulate
7.1.1 Emulate Company Information
7.1.2 Emulate Introduction and Business Overview
7.1.3 Emulate Muscle-on-a-Chip Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Emulate Muscle-on-a-Chip Product Offerings
7.1.5 Emulate Recent Developments
7.2 CN Bio
7.2.1 CN Bio Company Information
7.2.2 CN Bio Introduction and Business Overview
7.2.3 CN Bio Muscle-on-a-Chip Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 CN Bio Muscle-on-a-Chip Product Offerings
7.2.5 CN Bio Recent Developments
7.3 TissUse
7.3.1 TissUse Company Information
7.3.2 TissUse Introduction and Business Overview
7.3.3 TissUse Muscle-on-a-Chip Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 TissUse Muscle-on-a-Chip Product Offerings
7.3.5 TissUse Recent Developments
7.4 Axion Biosystems
7.4.1 Axion Biosystems Company Information
7.4.2 Axion Biosystems Introduction and Business Overview
7.4.3 Axion Biosystems Muscle-on-a-Chip Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Axion Biosystems Muscle-on-a-Chip Product Offerings
7.4.5 Axion Biosystems Recent Developments
7.5 Nortis
7.5.1 Nortis Company Information
7.5.2 Nortis Introduction and Business Overview
7.5.3 Nortis Muscle-on-a-Chip Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Nortis Muscle-on-a-Chip Product Offerings
7.5.5 Nortis Recent Developments
7.6 BioIVT
7.6.1 BioIVT Company Information
7.6.2 BioIVT Introduction and Business Overview
7.6.3 BioIVT Muscle-on-a-Chip Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 BioIVT Muscle-on-a-Chip Product Offerings
7.6.5 BioIVT Recent Developments
7.7 InSphero
7.7.1 InSphero Company Information
7.7.2 InSphero Introduction and Business Overview
7.7.3 InSphero Muscle-on-a-Chip Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 InSphero Muscle-on-a-Chip Product Offerings
7.7.5 InSphero Recent Developments
7.8 Mimetas
7.8.1 Mimetas Company Information
7.8.2 Mimetas Introduction and Business Overview
7.8.3 Mimetas Muscle-on-a-Chip Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Mimetas Muscle-on-a-Chip Product Offerings
7.8.5 Mimetas Recent Developments
7.9 Ascendance Biotechnology
7.9.1 Ascendance Biotechnology Company Information
7.9.2 Ascendance Biotechnology Introduction and Business Overview
7.9.3 Ascendance Biotechnology Muscle-on-a-Chip Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Ascendance Biotechnology Muscle-on-a-Chip Product Offerings
7.9.5 Ascendance Biotechnology Recent Developments
7.10 StemoniX
7.10.1 StemoniX Company Information
7.10.2 StemoniX Introduction and Business Overview
7.10.3 StemoniX Muscle-on-a-Chip Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 StemoniX Muscle-on-a-Chip Product Offerings
7.10.5 StemoniX Recent Developments
7.11 Tara Biosystems
7.11.1 Tara Biosystems Company Information
7.11.2 Tara Biosystems Introduction and Business Overview
7.11.3 Tara Biosystems Muscle-on-a-Chip Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Tara Biosystems Muscle-on-a-Chip Product Offerings
7.11.5 Tara Biosystems Recent Developments
7.12 BGI Genomics
7.12.1 BGI Genomics Company Information
7.12.2 BGI Genomics Introduction and Business Overview
7.12.3 BGI Genomics Muscle-on-a-Chip Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 BGI Genomics Muscle-on-a-Chip Product Offerings
7.12.5 BGI Genomics Recent Developments
8 Industry Chain Analysis
8.1 Muscle-on-a-Chip Industrial Chain
8.2 Muscle-on-a-Chip Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Muscle-on-a-Chip Sales Model
8.5.2 Sales Channels
8.5.3 Muscle-on-a-Chip Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Muscle-on-a-Chip market is projected to grow from US$ 359 million in 2025 to US$ 1784 million by 2032, at a CAGR of 26.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-31
Pages: 167
USD 4900.00
(Single User License)
The global Muscle-on-a-Chip market size was US$ 359 million in 2025 and is forecast to reach a readjusted size of US$ 1784 million by 2032 with a CAGR of 26.1% during the forecast period 2026-2032.
Published Date: 2026-03-31
Pages: 92
USD 4250.00
(Single User License)
The global Muscle-on-a-Chip market was valued at US$ 359 million in 2025 and is anticipated to reach US$ 1784 million by 2032, at a CAGR of 26.1% from 2026 to 2032.
Published Date: 2026-01-15
Pages: 124
USD 2900.00
(Single User License)
The global Muscle-on-a-Chip market is projected to grow from US$ 291 million in 2024 to US$ 1445 million by 2031, at a CAGR of 26.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 166
USD 4900.00
(Single User License)
The global Muscle-on-a-Chip market size was US$ 291 million in 2024 and is forecast to a readjusted size of US$ 1445 million by 2031 with a CAGR of 26.1% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 92
USD 4250.00
(Single User License)
The global market for Muscle-on-a-Chip was estimated to be worth US$ 291 million in 2024 and is forecast to a readjusted size of US$ 1445 million by 2031 with a CAGR of 26.1% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 126
USD 3950.00
(Single User License)
The global market for Muscle-on-a-Chip was valued at US$ 291 million in the year 2024 and is projected to reach a revised size of US$ 1445 million by 2031, growing at a CAGR of 26.1% during the forecast period.
Published Date: 2025-03-10
Pages: 94
USD 2900.00
(Single User License)
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published Date: 2024-04-28
Pages: 97
USD 2900.00
(Single User License)
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published Date: 2024-04-28
Pages: 113
USD 3950.00
(Single User License)
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published Date: 2024-04-28
Pages: 122
USD 4350.00
(Single User License)
The global Muscle-on-a-Chip market is projected to grow from US$ 359 million in 2025 to US$ 1784 million by 2032, at a CAGR of 26.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-31
Pages: 167
The global Muscle-on-a-Chip market size was US$ 359 million in 2025 and is forecast to reach a readjusted size of US$ 1784 million by 2032 with a CAGR of 26.1% during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 92
The global Muscle-on-a-Chip market was valued at US$ 359 million in 2025 and is anticipated to reach US$ 1784 million by 2032, at a CAGR of 26.1% from 2026 to 2032.
Published: 2026-01-15
Pages: 124
The global Muscle-on-a-Chip market is projected to grow from US$ 291 million in 2024 to US$ 1445 million by 2031, at a CAGR of 26.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 166
The global Muscle-on-a-Chip market size was US$ 291 million in 2024 and is forecast to a readjusted size of US$ 1445 million by 2031 with a CAGR of 26.1% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 92
The global market for Muscle-on-a-Chip was estimated to be worth US$ 291 million in 2024 and is forecast to a readjusted size of US$ 1445 million by 2031 with a CAGR of 26.1% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 126
The global market for Muscle-on-a-Chip was valued at US$ 291 million in the year 2024 and is projected to reach a revised size of US$ 1445 million by 2031, growing at a CAGR of 26.1% during the forecast period.
Published: 2025-03-10
Pages: 94
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published: 2024-04-28
Pages: 97
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published: 2024-04-28
Pages: 113
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published: 2024-04-28
Pages: 122
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now